Alap: ISHSP5HCE
iShares S&P 500 Health Care Sector UCITS ETF EUR | |
IE00B43HR379 | |
20.11.2015 | |
Equity | |
Részvény Sectors - Health Care | |
BlackRock iShares | |
BlackRock Advisors (UK) Limited | |
EUR | |
100 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 1.25% | 2.44% | 11.70% | 10.52% | 14.02% | - | - | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | - | - | - | - | - | ||||||
Volatilita od priemernej výkonnosti | - | - | - | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 99.64% | 99.64% | |
Kötvény | 0.00% | 0.00% | |
Other | |||
Pénz piac | 0.36% | 0.36% |
Aktíva | |
Počet akcíí | |
Počet dlhopisov |
Priebež. popl. | |
z toho Mng. popl. | |
Výk. prémia | |
Trans. popl. |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 33.47% |
Large | 50.49% |
Medium | 15.41% |
Small | 0.28% |
Micro | 0.00% |
P/E | |
P/BV |
Healthcare | 99.64% |
Government | 0.00 |
Corporate | 0.00 |
Derivatives | 0.36 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 0.00 |
AA | 0.97 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 99.03 |
United States | 99.64% |
Canada | |
Latin America | |
United Kingdom | |
Eurozone | |
Europe - ex Euro | |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 99.64% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Eli Lilly and Co | Healthcare | 12.48% | UnitedHealth Group Inc | Healthcare | 8.36% |
Johnson & Johnson | Healthcare | 6.52% | Merck & Co Inc | Healthcare | 6.1% |
AbbVie Inc | Healthcare | 5.51% | Thermo Fisher Scientific Inc | Healthcare | 4.14% |
Abbott Laboratories | Healthcare | 3.44% | Danaher Corp | Healthcare | 3.19% |
Amgen Inc | Healthcare | 3.01% | Pfizer Inc | Healthcare | 2.97% |